Default company panoramic image

Eagle Genomics Ltd

£410k 2nd close sought (£590k closed 1st) for £1m to bring to market a SaaS platform, enabling customers to analyse big data using Eagle IP

  • Stage $1M in TTM Revenue
  • Industry Biotechnology
  • Location Cambridge, England, GB
  • Currency GBP
  • Founded May 2008
  • Employees 12
  • Website

Company Summary

Eagle Genomics has five years’ experience providing outsourcing solutions for managing and analysing DNA data using bioinformatics -- the analysis of complex biological data using computational techniques. Eagle's services have added value to R&D processes and reduced time to market at life-science companies worldwide. Eagle’s is building on this experience to become a provider of specialist on-demand internet-based software with high margins.


  • Default avatar
    Alan Barrell

    Alan has 30 years' in senior executive positions in technology based industries. A Cambridge Angel, he was a founder shareholder in Library House Ltd, and is now Entrepreneur in Residence at the University's Centre for Entrepreneurial Learning and has several Visiting and Guest professorships at universities in the UK, China, and Finland. He is Chairman of Health Enterprise East Ltd and of Pneumacare Ltd., and a Director of Probe Scientific Ltd.

  • Default avatar
    David Flanders

    25+ years' international experience leading diverse teams and operations in successful delivery of technology and bioinformatics projects in the life sciences. Former positions include Site Head for the UK operation of Stem Cells, Inc; COO of a proteomics and systems biology start-up; and at Lion Bioscience. US experience both in the agricultural technology industry and at Stanford. PhD from the Australian National University.

  • Default avatar
    Christopher O'Connor

    Chartered Accountant with 20+ years experience in the high technology sector. Finance Director and CFO respectively, involved in sale of Kapiti Ltd to Misys plc in 1994 and Psytechnics Ltd to Netscout Systems, Inc (NTCT) in 2011. Involved in numerous funding events particularly with Cambridge Broadband Networks, CFO for 6 years, and at Psytechnics, CFO for 5 years. Led many commercial negotiations with companies. B.Sc from Bristol University.

  • Default avatar
    Richard Holland
    CBO & CO-Founder

    Richard holds a BSc in Computer Science from the University of Otago (New Zealand). He is a founder member of the Open Bioinformatics Foundation, first author on the original BioJava paper and an expert on the application of cloud computing to bioinformatics. He has worked in industry and academia and has worked in the UK, Singapore, and New Zealand.

  • Default avatar
    Abel Ureta-Vidal
    COO & Founder

    Abel has a PhD in Immuno-virology from the Pasteur Institute and an MBA from Cambridge University. He has 13 years’ experience in bioinformatics and project management, including at Genoscope and at the EBI where he was involved in the Ensembl and EMMA projects.

  • Default avatar
    William Spooner
    CTO & Founder

    Will has a PhD in Earth System Modelling from the University of Southampton and is a seasoned bioinformatician with many scientific papers to his name. He has worked on Ensembl, BioMart, Gramene and WormBase at EBI, the Wellcome Trust Sanger Institute and Cold Spring Harbor.

  • Default avatar
    Vernon Harten-Ash

    Vernon practised as a Medical Officer in the Royal Navy before joining the pharmaceutical industry and becoming a Medical Director. In 1994, he established the Harten Group. A committee member of BRAPP, he has an MBA from Wharton Business School in the USA.


  • Default avatar
    Taylor Vinters, Cambridge
    Default avatar
    BDO, Cambridge

Previous Investors

  • Default avatar
    None: no external capital, no debt, profitable since 2008 founding